drugset / Trial / NCT02466867
An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is an open label, multi-center, multi-application pharmacokinetic study in pediatric subjects with tinea corporis.
Timeline
- Start
- 2014-01
- Primary completion
- 2015-10
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naftifine | Other / unclassified | 3 g | Topical |
| Subject | Naftifine | Other / unclassified | 4 g | Topical |